135 related articles for article (PubMed ID: 3691609)
1. Effect of age on the pharmacokinetics of vinpocetine (Cavinton) and apovincaminic acid.
Miskolczi P; Vereczkey L; Szalay L; Göndöc C
Eur J Clin Pharmacol; 1987; 33(2):185-9. PubMed ID: 3691609
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of apovincaminic acid in dogs.
Vereczkey L; Pudleiner P
Pol J Pharmacol Pharm; 1987; 39(2):161-5. PubMed ID: 3432163
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of vinpocetine and apovincaminic acid in patients with impaired renal function.
Miskolczi P; Vereczkey L; Szalay L; Göndöcs CS
Eur J Drug Metab Pharmacokinet; 1984; 9(2):169-75. PubMed ID: 6745306
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans.
Miskolczi P; Kozma K; Polgár M; Vereczkey L
Eur J Drug Metab Pharmacokinet; 1990; 15(1):1-5. PubMed ID: 2384112
[TBL] [Abstract][Full Text] [Related]
5. Study on the absorption of vinpocetine and apovincaminic acid.
Pudleiner P; Vereczkey L
Eur J Drug Metab Pharmacokinet; 1993; 18(4):317-21. PubMed ID: 8020528
[TBL] [Abstract][Full Text] [Related]
6. Vinpocetine pharmacokinetics in elderly subjects.
Grandt R; Beitinger H; Schaltenbrand R; Braun W
Arzneimittelforschung; 1989 Dec; 39(12):1599-602. PubMed ID: 2624613
[TBL] [Abstract][Full Text] [Related]
7. Kinetic metabolism of vinpocetine in the rat.
Vereczkey L; Szentirmay Z; Szporny L
Arzneimittelforschung; 1979; 29(6):953-6. PubMed ID: 582790
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of vinpocetine and its metabolite, apovincaminic acid, in plasma and cerebrospinal fluid after intravenous infusion.
Polgár M; Vereczkey L; Nyáry I
J Pharm Biomed Anal; 1985; 3(2):131-9. PubMed ID: 16867695
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and comparative bioavailability of two vinpocetine tablet formulations in healthy volunteers by using the metabolite apovincaminic acid as pharmacokinetic parameter.
Vlase L; Bodiu B; Leucuta SE
Arzneimittelforschung; 2005; 55(11):664-8. PubMed ID: 16366040
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of vinpocetine (Cavinton) in dog.
Polgár M; Vereczkey L
Pol J Pharmacol Pharm; 1984; 36(4):407-12. PubMed ID: 6527972
[TBL] [Abstract][Full Text] [Related]
11. Determination of apovincaminic acid in human plasma by high-performance liquid chromatography.
Maya MT; Pais JP; Araújo HM; Morais JA
J Pharm Biomed Anal; 1996 Mar; 14(5):617-22. PubMed ID: 8738192
[TBL] [Abstract][Full Text] [Related]
12. Lack of pharmacokinetic interaction between vinpocetine and oxazepam.
Storm G; Oosterhuis B; Sollie FA; Visscher HW; Sommer W; Beitinger H; Jonkman JH
Br J Clin Pharmacol; 1994 Aug; 38(2):143-6. PubMed ID: 7981015
[TBL] [Abstract][Full Text] [Related]
13. Systemic exposure of vinpocetine in pregnant Sprague Dawley rats following repeated oral exposure: An investigation of fetal transfer.
Waidyanatha S; Toy H; South N; Gibbs S; Mutlu E; Burback B; McIntyre BS; Catlin N
Toxicol Appl Pharmacol; 2018 Jan; 338():83-92. PubMed ID: 29155086
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole does not change the oral bioavailability or pharmacokinetics of vinpocetine in rats.
Sozański T; Magdalan J; Trocha M; Szumny A; Merwid-Ląd A; Słupski W; Karaźniewicz-Łada M; Kiełbowicz G; Ksiądzyna D; Szeląg A
Pharmacol Rep; 2011; 63(5):1258-63. PubMed ID: 22180371
[TBL] [Abstract][Full Text] [Related]
15. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and disposition of vinpocetine in rats].
Yao JH; Su CY; Chu XY
Yao Xue Xue Bao; 1994; 29(2):81-5. PubMed ID: 8042515
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Determination of Vinpocetine and its Major Active Metabolite Apovincaminic Acid in Rats by UPLC-MS/MS and its Application to the Brain Tissue Distribution Study.
Wang M; Wang L; Sun J; Zhang L; Zhao L; Xiong Z
J Chromatogr Sci; 2018 Mar; 56(3):225-232. PubMed ID: 29206914
[TBL] [Abstract][Full Text] [Related]
18. Determination of apovincaminic acid in human plasma by gas-liquid chromatography.
Polgár M; Vereczkey L
J Chromatogr; 1982 May; 241(1):29-32. PubMed ID: 7107795
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of vinpocetine in humans.
Vereczkey L; Czira G; Tamás J; Szentirmay Z; Botár Z; Szporny L
Arzneimittelforschung; 1979; 29(6):957-60. PubMed ID: 582791
[TBL] [Abstract][Full Text] [Related]
20. Development of a sensitive enzyme immunoassay for the determination of vinpocetine in human plasma.
Reck B; Dingler E; Lohmann A
Arzneimittelforschung; 1992 Oct; 42(10):1171-4. PubMed ID: 1472136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
